查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067606

醫療人工智慧市場規模、佔有率和趨勢分析報告：按應用、最終用途、病人歷程、地區和細分市場預測（2026-2036 年）

Medical AI Market Size, Share & Trends Analysis Report By Application, By End Use, By Patient Journey, By Region, And Segment Forecasts, 2026 - 2036
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

醫療人工智慧市場概覽

全球醫療人工智慧市場預計到 2025 年將價值 426.2 億美元，預計將從 2026 年的 562 億美元成長到 2036 年的 1.05063 兆美元，2026 年至 2036 年的複合年成長率為 34.0%。

到 2025 年，北美醫療人工智慧市場將佔全球市場最大佔有率，達到 44.01%。

對微創手術和臨床精準度的需求不斷成長，對即時健康追蹤和個人化健康解決方案的採用率不斷提高，以及對經濟高效的藥物開發的需求不斷成長，這些都是推動市場成長的關鍵因素。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場動態
  • 人工智慧市場在藥物發現領域的最新趨勢
  • 人工智慧市場在醫療影像領域的最新趨勢
  • 技術概述
  • 案例研究的啟示：人工智慧在藥物研發的應用
  • 案例研究的啟示：計算病理學
  • 用例洞察：人工智慧在醫學影像中的應用
  • 從應用案例研究中獲得的啟示：人工智慧在行政工作流程中的應用
  • 商業環境分析工具

第4章：醫療人工智慧市場：按應用分類的估算與趨勢分析

  • 醫療人工智慧市場：基於應用的分析，2025 年和 2036 年
  • 醫療人工智慧市場：基於應用的分析，2025 年和 2036 年
  • 醫療人工智慧市場：按應用領域分類，2021-2036 年
  • 醫學影像人工智慧
  • 月球病理人工智慧
  • 基因組診斷人工智慧
  • 生物訊號診斷/生理訊號人工智慧
  • 多模態診斷人工智慧
  • 臨床/治療支持
  • 機器人輔助手術
  • 虛擬助手
  • 辦公室工作流程支援工具
  • 臨床檢測
  • 詐欺偵測
  • 網路安全
  • 減少用藥錯誤
  • 精準醫療
  • 藥物發現與開發
  • 生活方式管理和遠端患者監護
  • 穿戴式人工智慧
  • 病人
  • 其他

第5章：醫療人工智慧市場：按最終用途分類的估算和趨勢分析

  • 醫療人工智慧市場：按最終用途分類的分析，2025 年和 2036 年
  • 醫療人工智慧市場：按應用領域分類，2021-2036 年
  • 按最終用途
    • 醫療服務提供方
    • 生命科學
    • 病人
    • 付款人
    • 其他

第6章：醫療人工智慧市場：基於病人歷程的估算與趨勢分析

  • 醫療人工智慧市場：以病人歷程分析，2025 年和 2036 年
  • 醫療人工智慧市場：依病人歷程，2021-2036 年
  • 按類型分類的病人歷程
    • 預防保健
    • 診斷
    • 治療/干預
    • 後續護理/管理

第7章：醫療人工智慧市場：區域分析

  • 區域展望
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章：醫療人工智慧市場：競爭格局

  • 醫學影像診斷
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 2025年企業市場占有率（%）
    • 策略規劃
  • 數位病理學
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 基於數位業務病理學的企業市場占有率分析，2025 年（%）
    • 策略規劃
  • 基因組診斷
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 按基因組診斷分類的企業市場占有率，2025 年（%）
    • 策略規劃
  • 生物訊號診斷
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 2025年生物訊號診斷企業市場占有率（%）
    • 策略規劃
  • 多模態診斷
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 2025年多模態診斷企業市場占有率（%）
    • 策略規劃
  • 臨床/治療支持
    • 參與企業概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 2025年臨床和治療支援領域企業市場占有率（%）
    • 策略規劃
  • 藥物發現與開發
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 藥物發現與開發企業市場占有率分析，2025 年（%）
    • 策略規劃
  • 機器人輔助手術
    • 參與企業概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 2025年機器人輔助手術市企業市場占有率）(%)
    • 策略規劃
  • 管理工作流程助手
    • 參與企業概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 依管理工作流程助理分類的企業市場占有率分析，2025 年（%）
    • 策略規劃
  • 連網醫療設備
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年互聯醫療設備市佔率分析（依企業市場占有率分列）
    • 策略規劃
  • 臨床檢測
    • 參與公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 臨床實驗室企業市場占有率分析，2025 年（%）
    • 策略規劃
  • 詐欺偵測
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 以詐欺檢測方法分類的企業市場占有率分析，2025 年（%）
    • 策略規劃
  • 網路安全
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 網路安全企業市場占有率分析，2025 年（%）
    • 策略規劃
  • 減少用藥錯誤
    • 參與企業概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 以減少用藥錯誤計算的企業市場占有率分析（2025 年）(%)
    • 策略規劃
  • 精準醫療
    • 公司概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 精準醫療企業市場占有率分析，2025 年（%）
    • 策略規劃
  • 穿戴式裝置
    • 參與企業概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 穿戴式裝置企業市場占有率），2025 年（%）
    • 策略規劃
  • 病人參與
    • 參與企業概況
    • 產品基準測試
    • 公司和競爭對手的分類
    • 2025年公司市場分析
    • 按病人參與的企業市場占有率分析，2025 年（%）
    • 策略規劃
Product Code: GVR-4-68040-925-5

Medical AI Market Summary

The global medical AI market size was estimated at USD 42.62 billion in 2025 and is projected to grow from USD 56.20 billion in 2026 to USD 1,050.63 billion by 2036, at a CAGR of 34.0% from 2026 to 2036. The North America Medical AI market held the largest share of 44.01% of the global market in 2025.

Increasing demand for minimally invasive surgery and clinical precision, growing adoption of real-time health tracking and personalized wellness solutions, increasing demand for minimally invasive surgery and clinical precision, and rising demand for cost-effective drug development are significant factors contributing to market growth.

Global Medical AI Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2036. For this study, Grand View Research has segmented the medical AI market report based on, end use, application, patient journey, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2036)
  • Medical Imaging Diagnostics AI
  • Digital Pathology AI
  • Genomic Diagnostics AI
  • Bio-signal Diagnostics/Physiologic Signal AI
  • Multimodal Diagnostics AI
  • Clinical & Treatment Support
  • Robot-Assisted Surgery
  • Virtual Assistants
  • Administrative Workflow Assistants
  • Clinical Trials
  • Fraud Detection
  • Cybersecurity
  • Dosage Error Reduction
  • Precision medicine
  • Drug discovery & development
  • Lifestyle management & remote patient monitoring
  • Wearables
  • Patient engagement
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2036)
  • Healthcare Providers
    • Hospitals
    • Physician groups/clinics
    • Ambulatory / specialty care centers
    • Others (Dialysis centers, Cardiac diagnostic centers, etc.)
  • Life Sciences
    • Pharmaceutical companies
    • Biotechnology companies
    • CROs / clinical research organizations
  • Patient
  • Payer
  • Others (Academic medical centers, Research institutes, etc.)
  • Patient Journey Outlook (Revenue, USD Million, 2021 - 2036)
  • Prevention/Wellness
  • Diagnostics
  • Treatment / Intervention
  • Post-care / Management
  • Regional Outlook (Revenue, USD Million, 2021 - 2036)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation And Scope
    • 1.1.1. Segment Definition
      • 1.1.1.1. Application Segment
      • 1.1.1.2. End Use Segment
  • 1.2. Regional Scope
    • 1.2.1. Estimates And Forecast Timeline
  • 1.3. Objectives
    • 1.3.1. Objective - 1
    • 1.3.2. Objective - 2
    • 1.3.3. Objective - 3
  • 1.4. Research Methodology
  • 1.5. Information Procurement
  • 1.6. Market-specific Research Models
    • 1.6.1. Consensus-based Estimates & Forecasting
    • 1.6.2. Model 1: Commodity Flow Analysis
    • 1.6.3. Model 2: Parent Market Analysis
    • 1.6.4. Model 3: Country-level Multivariate Analysis Assumptions
    • 1.6.5. Model 4: Segment-level Multivariate Analysis Assumptions
      • 1.6.5.1. Medical AI Market CAGR Calculation
      • 1.6.5.2. Variables Used For Market Analysis
      • 1.6.5.3. Regional Analysis Matrix
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Application Segment Outlook - Part 1
  • 2.3. Application Segment Outlook - Part 2
  • 2.4. End Use And Patient Journey Segment Outlook
  • 2.5. Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver Analysis
      • 3.1.1.1. Growing Adoption Of Real-time Health Tracking And Personalized Wellness Solutions
      • 3.1.1.2. Rising Prevalence Of Cancer And Increasing Demand For Early Detection And Classification Of Cancer
        • 3.1.1.2.1. Case Study 1
      • 3.1.1.3. Increasing Demand For Minimally Invasive Surgery And Clinical Precision
      • 3.1.1.4. Rising Demand For Cost-effective Drug Development
      • 3.1.1.5. Growing Focus On Precision Medicine And Targeted Drug Development
        • 3.1.1.5.1. Case Study 2
        • 3.1.1.5.2. Case Study 3
        • 3.1.1.5.3. Targeted Drug Development
      • 3.1.1.6. Increasing Clinical Trials In Drug Repurposing
      • 3.1.1.7. Growing Focus On Remote Patient Monitoring
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. Cybersecurity And Privacy Concerns
      • 3.1.2.2. Highly Regulated Industry
      • 3.1.2.3. Limited Measurement Accuracy And Insufficient Clinical Validation
    • 3.1.3. Market Opportunity Analysis
      • 3.1.3.1. Opportunities In Digital Pathology AI Market
        • 3.1.3.1.1. Emergence Of Quantitative Continuous Scoring (QCS) In Digital Pathology
      • 3.1.3.2. Opportunities In AI In Drug Discovery Market
        • 3.1.3.2.1. Quantum Simulation As An Emerging Technology in AI-Enabled Drug Discovery
          • 3.1.3.2.1.1. Use Case Analysis: Kvantify Transforms Quantum Simulations For Drug Discovery With Gefion Supercomputer
        • 3.1.3.2.2. New AI-based Repurposing Approaches
        • 3.1.3.2.3. Disease- And Population-level Opportunities
      • 3.1.3.3. Opportunities In Wearable AI Market
        • 3.1.3.3.1. Gesture Recognition And Contactless Interaction
    • 3.1.4. Market Challenges Analysis
      • 3.1.4.1. Interoperability And Ecosystem Integration
      • 3.1.4.2. High Implementation And Procurement Costs
  • 3.2. Recent Developments In The AI In Drug Discovery Market
  • 3.3. Recent Developments In The AI In Medical Imaging Market
  • 3.4. Technological Overview
    • 3.4.1. Technological Trends In AI In Drug Discovery
      • 3.4.1.1. Advanced Algorithm Integration, Machine Learning, And Data Analytics In Drug Discovery
    • 3.4.2. Technological Trends In Digital Pathology/Computational Pathology AI
  • 3.5. Case Study Insights: AI In Drug Discovery
    • 3.5.1. Case Study 1: AI-driven Molecular Intelligence For Accelerated Drug Discovery
    • 3.5.2. Case Study 2: Syneos Health Accelerates Clinical Trials With Azure OpenAI Service
    • 3.5.3. Case Study 3: Novo Nordisk Transforms Clinical Study Reports With Generative AI
    • 3.5.4. Case Study 4: Accelerating Drug Ranking With Wipro Limited's AI System
    • 3.5.5. Case Study 5: Deepdrug Framework For Alzheimer's Disease
  • 3.6. Case Study Insights: Computational Pathology
    • 3.6.1. Case Study 1: AI-enhanced Detection Of High-risk Prostate Cancer Features With Aiforia Prostate Cancer Suite
    • 3.6.2. Case Study 2: Building Tools For Machine Learning And Artificial Intelligence In Computational Pathology
  • 3.7. Case Study Insights: AI In Medical Imaging
    • 3.7.1. Case Study 1: Enhancing Echocardiography Workflow And Ergonomics With GE Healthcare's Vivid AI Ultrasound System
    • 3.7.2. Case Study 2: Accelerating ECG Diagnosis And Patient Care At Cardioparc With Cardiomatics AI-powered Analysis
  • 3.8. Case Study Insights: AI In Administrative Workflow
    • 3.8.1. Case Study 1: Transforming Front Desk Efficiency With Conversational AI In A Small Outpatient Clinic
  • 3.9. Business Environment Analysis Tools
    • 3.9.1. Porter's Five Forces Analysis
    • 3.9.2. Pestel Analysis

Chapter 4. Medical AI Market: Application Estimates & Trend Analysis

  • 4.1. Medical AI Market: Application Segment Dashboard
  • 4.2. Medical AI Market: Application Segment Dashboard
  • 4.3. Medical AI Market: Application Analysis, 2025 & 2036
  • 4.4. Medical AI Market: Application Analysis, 2025 & 2036
  • 4.5. Medical AI Market, By Application, 2021 - 2036 (USD Billion)
  • 4.6. Medical Imaging Diagnostics AI
    • 4.6.1. Medical Imaging Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.7. Digital Pathology AI
    • 4.7.1. Digital Pathology AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.8. Genomic Diagnostics AI
    • 4.8.1. Genomic Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.9. Bio-signal Diagnostics/Physiologic Signal AI
    • 4.9.1. Bio-signal Diagnostics/Physiologic Signal AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.10. Multimodal Diagnostics AI
    • 4.10.1. Multimodal Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.11. Clinical & Treatment Support
    • 4.11.1. Clinical & Treatment Support Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.12. Robot-assisted Surgery
    • 4.12.1. Robot-assisted Surgery Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.13. Virtual Assistants
    • 4.13.1. Virtual Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.14. Administrative Workflow Assistants
    • 4.14.1. Administrative Workflow Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.15. Clinical Trials
    • 4.15.1. Clinical Trials Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.16. Fraud Detection
    • 4.16.1. Fraud Detection Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.17. Cybersecurity
    • 4.17.1. Cybersecurity Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.18. Dosage Error Reduction
    • 4.18.1. Dosage Error Reduction Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.19. Precision Medicine
    • 4.19.1. Precision Medicine Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.20. Drug Discovery & Development
    • 4.20.1. Drug Discovery & Development Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.21. Lifestyle Management & Remote Patient Monitoring
    • 4.21.1. Lifestyle Management & Remote Patient Monitoring Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.22. Wearable AI
    • 4.22.1. Wearable AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.23. Patient
    • 4.23.1. Patient Engagement Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 4.24. Others
    • 4.24.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)

Chapter 5. Medical AI Market: End Use Estimates & Trend Analysis

  • 5.1. Medical AI Market: End Use Segment Dashboard
  • 5.2. Medical AI Market: End Use Analysis, 2025 & 2036
  • 5.3. Medical AI Market, By End Use, 2021 - 2036 (USD Billion)
  • 5.4. By End Use
    • 5.4.1. Healthcare Providers
      • 5.4.1.1. Hospitals
        • 5.4.1.1.1. Hospitals Market Estimates And Forecasts, 2021 - 2036 (USD Million)
      • 5.4.1.2. Physician Groups/Clinics
        • 5.4.1.2.1. Physician Groups/Clinics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
      • 5.4.1.3. Ambulatory / Specialty Care Centers
        • 5.4.1.3.1. Ambulatory / Specialty Care Centers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
      • 5.4.1.4. Others
        • 5.4.1.4.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.2. Life Sciences
      • 5.4.2.1. Pharmaceutical Companies
        • 5.4.2.1.1. Pharmaceutical Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
      • 5.4.2.2. Biotechnology Companies
        • 5.4.2.2.1. Biotechnology Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
      • 5.4.2.3. Cros / Clinical Research Organizations
        • 5.4.2.3.1. Cros / Clinical Research Organizations Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.3. Patient
      • 5.4.3.1. Patient Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.4. Payers
      • 5.4.4.1. Payers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)

Chapter 6. Medical AI Market: Patient Journey Estimates & Trend Analysis

  • 6.1. Medical AI Market: Patient Journey Segment Dashboard
  • 6.2. Medical AI Market: Patient Journey Analysis, 2025 & 2036
  • 6.3. Medical AI Market, By Patient Journey, 2021 - 2036 (USD Billion)
  • 6.4. By Patient Journey
    • 6.4.1. Prevention/Wellness
      • 6.4.1.1. Prevention/Wellness Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 6.4.2. Diagnostics
      • 6.4.2.1. Diagnostics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 6.4.3. Treatment / Intervention
      • 6.4.3.1. Treatment / Intervention Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 6.4.4. Post-care / Management
      • 6.4.4.1. Post-care / Management Market Estimates And Forecasts, 2021 - 2036 (USD Million)

Chapter 7. Medical AI Market: Regional Analysis

  • 7.1. Regional Outlook
  • 7.2. North America
    • 7.2.1. North America Medical AI Market, 2021 - 2036 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Regulatory Framework
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. U.S. Medical AI Market, 2021 - 2036 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Regulatory Framework
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Canada Medical AI Market, 2021 - 2036 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Regulatory Framework
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Mexico Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Regulatory Framework
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. UK Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Regulatory Framework
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Regulatory Framework
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. France Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Regulatory Framework
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Italy Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Regulatory Framework
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Spain Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Regulatory Framework
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Denmark Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Regulatory Framework
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Sweden Medical AI Market, 2021 - 2036 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Regulatory Framework
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Norway Medical AI Market, 2021 - 2036 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Medical AI Market, 2021 - 2036 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. China Medical AI Market, 2021 - 2036 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Japan Medical AI Market, 2021 - 2036 (USD Million).
    • 7.4.4. South Korea
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. South Korea Medical AI Market, 2021 - 2036 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Regulatory Framework
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. India Medical AI Market, 2021 - 2036 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Regulatory Framework
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Australia Medical AI Market, 2021 - 2036 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Regulatory Framework
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Thailand Medical AI Market, 2021 - 2036 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Medical AI Market, 2021 - 2036 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Brazil Medical AI Market, 2021 - 2036 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Argentina Medical AI Market, 2021 - 2036 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Medical AI Market, 2021 - 2036 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. South Africa Medical AI Market, 2021 - 2036 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Saudi Arabia Medical AI Market, 2021 - 2036 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. UAE Medical AI Market, 2021 - 2036 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Kuwait Medical AI Market, 2021 - 2036 (USD Million)

Chapter 8. Medical AI Market: Competitive Landscape

  • 8.1. Medical Imaging Diagnostics
    • 8.1.1. Participants' Overview
      • 8.1.1.1. Aidoc
      • 8.1.1.2. Lunit INC
      • 8.1.1.3. Behold.ai
      • 8.1.1.4. Digital Diagnostics INC.
      • 8.1.1.5. Tempus
      • 8.1.1.6. Viz.ai, INC.
      • 8.1.1.7. Us2.ai
      • 8.1.1.8. Rad AI
      • 8.1.1.9. Gleamer
      • 8.1.1.10. Enlitic
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Company/Competition Categorization
    • 8.1.5. Company Market Position Analysis, 2025
    • 8.1.6. Company Market Share Analysis By Medical Imaging Diagnostics, 2025 (%)
    • 8.1.7. Strategy Mapping
      • 8.1.7.1. New Product Launch
      • 8.1.7.2. Partnerships And Collaborations
      • 8.1.7.3. Regional Expansion
      • 8.1.7.4. Merger & Acquisition
      • 8.1.7.5. Others
  • 8.2. Digital Pathology
    • 8.2.1. Participants' Overview
      • 8.2.1.1. Proscia INC.
      • 8.2.1.2. Aignostics, INC.
      • 8.2.1.3. Aiforia
      • 8.2.1.4. Dedalus S.p.a
      • 8.2.1.5. Gestalt
      • 8.2.1.6. Paige AI
      • 8.2.1.7. Path AI
      • 8.2.1.8. Ibex Medical Analytics
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Company/Competition Categorization
    • 8.2.5. Company Market Position Analysis, 2025
    • 8.2.6. Company Market Share Analysis By Digital Pathology, 2025 (%)
    • 8.2.7. Strategy Mapping
      • 8.2.7.1. New Product Launch
      • 8.2.7.2. Partnerships And Collaborations
      • 8.2.7.3. Regional Expansion
      • 8.2.7.4. Others
  • 8.3. Genomic Diagnostics
    • 8.3.1. Participants' Overview
      • 8.3.1.1. Caris Life Sciences
      • 8.3.1.2. Tempus
      • 8.3.1.3. Sophia Genetics
      • 8.3.1.4. Genedx
      • 8.3.1.5. Fabric Genomics
      • 8.3.1.6. Genomenon
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Company/Competition Categorization
    • 8.3.5. Company Market Position Analysis, 2025
    • 8.3.6. Company Market Share Analysis By Genomic Diagnostics, 2025 (%)
    • 8.3.7. Strategy Mapping
      • 8.3.7.1. Product Launch
      • 8.3.7.2. Partnerships And Collaborations
      • 8.3.7.3. Product Expansion
      • 8.3.7.4. Merger & Acquisition
  • 8.4. Bio-signal Diagnostics
    • 8.4.1. Participants' Overview
      • 8.4.1.1. Irhythm Technologies, INC.
      • 8.4.1.2. Beacon Biosignals
      • 8.4.1.3. Eko Health
      • 8.4.1.4. Anumana
      • 8.4.1.5. Cardiomatics
      • 8.4.1.6. Withings Health
      • 8.4.1.7. Medicalgorithmics.com
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Company/Competition Categorization
    • 8.4.5. Company Market Position Analysis, 2025
    • 8.4.6. Company Market Share Analysis By Bio-signal Diagnostics, 2025 (%)
    • 8.4.7. Strategy Mapping
      • 8.4.7.1. Product Launch
      • 8.4.7.2. Partnerships And Collaborations
      • 8.4.7.3. Merger & Acquisition
  • 8.5. Multimodal Diagnostics
    • 8.5.1. Participants' Overview
      • 8.5.1.1. Tempus
      • 8.5.1.2. Viz.ai, INC.
      • 8.5.1.3. Aidoc
      • 8.5.1.4. Rapidai
      • 8.5.1.5. Annalise.ai
      • 8.5.1.6. Qure.ai
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Company/Competition Categorization
    • 8.5.5. Company Market Position Analysis, 2025
    • 8.5.6. Company Market Share Analysis By Multimodal Diagnostics, 2025 (%)
    • 8.5.7. Strategy Mapping
      • 8.5.7.1. Product Launch
      • 8.5.7.2. Partnerships And Collaborations
      • 8.5.7.3. Others
  • 8.6. Clinical & Treatment Support
    • 8.6.1. Participants' Overview
      • 8.6.1.1. Openevidence
      • 8.6.1.2. Epic Systems Corporation
      • 8.6.1.3. Regard
      • 8.6.1.4. Ambience Healthcare
      • 8.6.1.5. Glass Health
      • 8.6.1.6. Wolters Kluwer
      • 8.6.1.7. Corti
      • 8.6.1.8. Nuance Communications
      • 8.6.1.9. Navina AI
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Company/Competition Categorization
    • 8.6.5. Company Market Position Analysis, 2025
    • 8.6.6. Company Market Share Analysis By Clinical & Treatment Support, 2025 (%)
    • 8.6.7. Strategy Mapping
      • 8.6.7.1. Product Launch
      • 8.6.7.2. Partnerships And Collaborations
      • 8.6.7.3. Others
  • 8.7. Drug Discovery & Development
    • 8.7.1. Participants' Overview
      • 8.7.1.1. Bostongene Corporation
      • 8.7.1.2. Benevolentai
      • 8.7.1.3. Innophore
      • 8.7.1.4. Bioxcel Therapeutics INC.
      • 8.7.1.5. Owkin, INC
      • 8.7.1.6. Insilico Medicine
      • 8.7.1.7. Healx
      • 8.7.1.8. IBM
      • 8.7.1.9. Google (DeepMind)
      • 8.7.1.10. Biosymetrics, INC.
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Company/Competition Categorization
    • 8.7.5. Company Market Position Analysis, 2025
    • 8.7.6. Company Market Share Analysis By Drug Discovery & Development, 2025 (%)
    • 8.7.7. Strategy Mapping
      • 8.7.7.1. Product/Service Launch
      • 8.7.7.2. Partnerships And Collaborations
      • 8.7.7.3. Regional Expansion
      • 8.7.7.4. Merger & Acquisition
      • 8.7.7.5. Others
  • 8.8. Robot-assisted Surgery
    • 8.8.1. Participants' Overview
      • 8.8.1.1. Intuitive Surgical
      • 8.8.1.2. Stryker
      • 8.8.1.3. Medtronic
      • 8.8.1.4. Johnson & Johnson Medtech
      • 8.8.1.5. Zimmer Biomet
      • 8.8.1.6. Activ Surgical
      • 8.8.1.7. Andromeda Surgical, INC.
      • 8.8.1.8. Algosurg
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Company/Competition Categorization
    • 8.8.5. Company Market Position Analysis, 2025
    • 8.8.6. Company Market Share Analysis By Robot-assisted Surgery, 2025 (%)
    • 8.8.7. Strategy Mapping
      • 8.8.7.1. New Product Launch
      • 8.8.7.2. Partnerships And Collaborations
      • 8.8.7.3. Regulatory Approval
      • 8.8.7.4. Regional Expansion
      • 8.8.7.5. Merger & Acquisition
      • 8.8.7.6. Others
  • 8.9. Administrative Workflow Assistants
    • 8.9.1. Participants' Overview
      • 8.9.1.1. Waystar
      • 8.9.1.2. Abridge
      • 8.9.1.3. Notable Health
      • 8.9.1.4. Ambience Healthcare
      • 8.9.1.5. R1 Rcm
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Company/Competition Categorization
    • 8.9.5. Company Market Position Analysis, 2025
    • 8.9.6. Company Market Share Analysis By Administrative Workflow Assistants, 2025 (%)
    • 8.9.7. Strategy Mapping
      • 8.9.7.1. Product/Service Launch
      • 8.9.7.2. Partnerships And Collaborations
      • 8.9.7.3. Merger & Acquisition
  • 8.10. Connected Medical Devices
    • 8.10.1. Participants' Overview
      • 8.10.1.1. Medtronic
      • 8.10.1.2. Abbott
      • 8.10.1.3. Dexcom
      • 8.10.1.4. Irhythm Technologies
      • 8.10.1.5. GE Healthcare
      • 8.10.1.6. Siemens Healthineers
      • 8.10.1.7. Koninklijke Philips N.v.
      • 8.10.1.8. Validic, INC.
      • 8.10.1.9. Biointellisense
      • 8.10.1.10. Healthsnap, INC.
      • 8.10.1.11. Roche
      • 8.10.1.12. Idoven
      • 8.10.1.13. Datos
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Company/Competition Categorization
    • 8.10.5. Company Market Position Analysis, 2025
    • 8.10.6. Strategy Mapping
      • 8.10.6.1. Product Launch
      • 8.10.6.2. Partnerships And Collaborations
      • 8.10.6.3. Product Expansion
  • 8.11. Clinical Trials
    • 8.11.1. Participants' Overview
      • 8.11.1.1. Iqvia INC
      • 8.11.1.2. Dassault Systemes (Medidata)
      • 8.11.1.3. Insilico Medicine
      • 8.11.1.4. Tempus (Deep6.ai)
      • 8.11.1.5. NVIDIA Corporation
      • 8.11.1.6. Unlearn.ai, INC.
      • 8.11.1.7. Saama
      • 8.11.1.8. Antidote Technologies, INC.
      • 8.11.1.9. Phesi
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Company/Competition Categorization
    • 8.11.5. Company Market Position Analysis, 2025
    • 8.11.6. Company Market Share Analysis By Clinical Trials, 2025 (%)
    • 8.11.7. Strategy Mapping
      • 8.11.7.1. Product Launch
      • 8.11.7.2. Partnerships And Collaborations
      • 8.11.7.3. Merger & Acquisition
  • 8.12. Fraud Detection
    • 8.12.1. Participants' Overview
      • 8.12.1.1. Codoxo
      • 8.12.1.2. Experian Information Solutions, INC.
      • 8.12.1.3. H2o.ai
      • 8.12.1.4. Optum, INC. (Unitedhealth Group)
      • 8.12.1.5. General Dynamics Information Technology, INC.
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Company/Competition Categorization
    • 8.12.5. Company Market Position Analysis, 2025
    • 8.12.6. Company Market Share Analysis By Fraud Detection, 2025 (%)
    • 8.12.7. Strategy Mapping
      • 8.12.7.1. Product Launch
      • 8.12.7.2. Partnerships And Collaborations
      • 8.12.7.3. Product Expansion
      • 8.12.7.4. Merger & Acquisition
  • 8.13. Cybersecurity
    • 8.13.1 Participants' Overview
      • 8.13.1.1. CrowdStrike
      • 8.13.1.2. Palo Alto Networks
      • 8.13.1.3. Asimily
      • 8.13.1.4. Arctic Wolf
      • 8.13.1.5. Claroty
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Company/Competition Categorization
    • 8.13.5. Company Market Position Analysis, 2025
    • 8.13.6. Company Market Share Analysis By Cybersecurity, 2025 (%)
    • 8.13.7. Strategy Mapping
      • 8.13.7.1. Product Launch
      • 8.13.7.2. Merger & Acquisition
  • 8.14. Dosage Error Reduction
    • 8.14.1. Participants' Overview
      • 8.14.1.1. Mvision AI INC.
      • 8.14.1.2. Dosemerx
      • 8.14.1.3. Merative
      • 8.14.1.4. Medaware
      • 8.14.1.5. Aicure
    • 8.14.2. Financial Performance
    • 8.14.3. Product Benchmarking
    • 8.14.4. Company/Competition Categorization
    • 8.14.5. Company Market Position Analysis, 2025
    • 8.14.6. Company Market Share Analysis By Dosage Error Reduction, 2025 (%)
    • 8.14.7. Strategy Mapping
      • 8.14.7.1. Regulatory Approval
      • 8.14.7.2. Partnerships And Collaborations
  • 8.15. Precision Medicine
    • 8.15.1. Participants' Overview
      • 8.15.1.1. Bioxcel Therapeutics INC.
      • 8.15.1.2. Sanofi
      • 8.15.1.3. NVIDIA Corporation
      • 8.15.1.4. Alphabet INC. (Google)
      • 8.15.1.5. IBM
      • 8.15.1.6. Microsoft
    • 8.15.2. Financial Performance
    • 8.15.3. Product Benchmarking
    • 8.15.4. Company/Competition Categorization
    • 8.15.5. Company Market Position Analysis, 2025
    • 8.15.6. Company Market Share Analysis By Precision Medicine, 2025 (%)
    • 8.15.7. Strategy Mapping
      • 8.15.7.1. Partnerships And Collaborations
      • 8.15.7.2. Product Expansion
  • 8.16. Wearables
    • 8.16.1. Participant's Overview
      • 8.16.1.1. Samsung Electronics Co., Ltd.
      • 8.16.1.2. Meta
      • 8.16.1.3. Fitbit, INC.
      • 8.16.1.4. Garmin LTD.
      • 8.16.1.5. Google, INC. (Alphabet)
      • 8.16.1.6. Huawei Technologies Co., Ltd.
      • 8.16.1.7. Xiaomi
      • 8.16.1.8. Apple, INC.
    • 8.16.2. Financial Performance
    • 8.16.3. Product Benchmarking
    • 8.16.4. Company/Competition Categorization
    • 8.16.5. Company Market Position Analysis, 2025
    • 8.16.6. Company Market Share Analysis By Wearables, 2025 (%)
    • 8.16.7. Strategy Mapping
      • 8.16.7.1. New Product Launch
      • 8.16.7.2. Mergers And Acquisitions
      • 8.16.7.3. Collaborations & Partnerships
      • 8.16.7.4. Regional Expansion
      • 8.16.7.5. Other Strategies
  • 8.17. Patient Engagement
    • 8.17.1. Participants' Overview
      • 8.17.1.1. Medadvisor Solutions
      • 8.17.1.2. Innovaccer, INC.
      • 8.17.1.3. Enlivenhealth (A Subdivision Of Omnicell, INC.)
      • 8.17.1.4. Empirx Health, LLC.
      • 8.17.1.5. IBM
      • 8.17.1.6. Oracle
    • 8.17.2. Financial Performance
    • 8.17.3. Product Benchmarking
    • 8.17.4. Company/Competition Categorization
    • 8.17.5. Company Market Position Analysis, 2025
    • 8.17.6. Company Market Share Analysis By Patient Engagement, 2025 (%)
    • 8.17.7. Strategy Mapping
      • 8.17.7.1. Product Launch
      • 8.17.7.2. Partnerships And Collaborations
      • 8.17.7.3. Merger & Acquisition

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Medical AI market, by region, 2021 - 2036 (USD Million)
  • Table 3 Global Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 4 Global Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 5 Global Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 6 North America Medical AI market, by country, 2021 - 2036 (USD Million)
  • Table 7 North America Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 8 North America Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 9 North America Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 10 U.S. Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 11 U.S. Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 12 U.S. Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 13 Canada Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 14 Canada Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 15 Canada Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 16 Mexico Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 17 Mexico Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 18 Mexico Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 19 Europe Medical AI market, by country, 2021 - 2036 (USD Million)
  • Table 20 Europe Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 21 Europe Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 22 Europe Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 23 UK Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 24 UK Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 25 UK Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 26 Germany Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 27 Germany Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 28 Germany Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 29 France Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 30 France Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 31 France Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 32 Italy Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 33 Italy Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 34 Italy Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 35 Spain Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 36 Spain Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 37 Spain Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 38 Denmark Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 39 Denmark Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 40 Denmark Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 41 Sweden Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 42 Sweden Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 43 Sweden Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 44 Norway Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 45 Norway Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 46 Norway Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 47 Asia Pacific Medical AI market, by country, 2021 - 2036 (USD Million)
  • Table 48 Asia Pacific Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 49 Asia Pacific Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 50 Asia Pacific Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 51 China Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 52 China Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 53 China Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 54 Japan Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 55 Japan Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 56 Japan Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 57 India Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 58 India Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 59 India Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 60 South Korea Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 61 South Korea Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 62 South Korea Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 63 Australia Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 64 Australia Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 65 Australia Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 66 Thailand Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 67 Thailand Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 68 Thailand Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 69 Latin America Medical AI market, by country, 2021 - 2036 (USD Million)
  • Table 70 Latin America Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 71 Latin America Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 72 Latin America Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 73 Brazil Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 74 Brazil Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 75 Brazil Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 76 Argentina Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 77 Argentina Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 78 Argentina Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 79 Middle East & Africa Medical AI market, by country, 2021 - 2036 (USD Million)
  • Table 80 Middle East & Africa Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 81 Middle East & Africa Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 82 Middle East & Africa Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 83 South Africa Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 84 South Africa Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 85 South Africa Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 86 Saudi Arabia Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 87 Saudi Arabia Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 88 Saudi Arabia Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 89 UAE Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 90 UAE Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 91 UAE Medical AI market, by application, 2021 - 2036 (USD Million)
  • Table 92 Kuwait Medical AI market, by patient journey, 2021 - 2036 (USD Million)
  • Table 93 Kuwait Medical AI market, by end use, 2021 - 2036 (USD Million)
  • Table 94 Kuwait Medical AI market, by application, 2021 - 2036 (USD Million)

List of Figures

  • Fig. 1 Medical AI market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 Market snapshot
  • Fig. 7 Application segment outlook - Part 1
  • Fig. 8 Application segment outlook - Part 2
  • Fig. 9 End use and patient journey segment outlook
  • Fig. 10 Competitive landscape
  • Fig. 11 Market dynamics
  • Fig. 12 Market driver relevance analysis
  • Fig. 13 Estimated new cancer cases in the U.S. in 2025
  • Fig. 14 Areas of interest most likely to benefit from AI in the next 10 years
  • Fig. 15 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
  • Fig. 16 Approximate number of procedures performed on da Vinci surgical systems in the U.S. and outside the U.S. (OUS) for the periods presented. ('000)
  • Fig. 17 Case study insights: Leveraging ai to develop more personalized cancer treatment strategies at the University of Oxford
  • Fig. 18 Key features of artificial intelligence in remote patient monitoring
  • Fig. 19 Strategic initiatives related to disease/indication
  • Fig. 20 Market restraint relevance analysis
  • Fig. 21 Few notable fundings in the AI in drug repurposing industry
  • Fig. 22 Recent AI launches and collaborations in digital and computational pathology by market players
  • Fig. 23 Benefits of AI integration in digital and computational pathology
  • Fig. 24 Case study 1: AI-driven molecular intelligence for accelerated drug discovery
  • Fig. 25 Case study 4: Accelerating drug ranking with Wipro Limited's AI system
  • Fig. 26 Case study 5: Deep Drug framework for Alzheimer's disease
  • Fig. 27 Case study 1: AI-powered prostate cancer diagnostics
  • Fig. 28 Case study 2: Enhancing echocardiography workflow and ergonomics with GE Healthcare's Vivid Ai Ultrasound System
  • Fig. 29 Case study 3: Accelerating ECG diagnosis and patient care at CardioParc with Cardiomatics AI-powered analysis
  • Fig. 30 Medical AI market: Porter's five forces analysis
  • Fig. 31 Medical AI market: PESTEL analysis
  • Fig. 32 Medical AI market: Application outlook key takeaways (USD Billion)
  • Fig. 33 Medical AI market: Application outlook key takeaways (USD Billion)
  • Fig. 34 Medical AI market: Application movement analysis, 2025 & 2036
  • Fig. 35 Medical AI market: Application movement analysis, 2025 & 2036
  • Fig. 36 Medical imaging diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 37 Digital pathology AI market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 38 Genomic diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 39 Bio-signal diagnostics/physiologic signal AI market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 40 Case study insights: Multimodal craniocerebral diagnosis using 3D CT and image reports
  • Fig. 41 Multimodal diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 42 Clinical & treatment support market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 43 Robot-assisted surgery market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 44 Virtual assistants market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 45 Administrative workflow assistants market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 46 Clinical trials market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 47 Fraud detection market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 48 Cybersecurity market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 49 Dosage error reduction market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 50 Precision medicine market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 51 Drug discovery & development market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 52 Lifestyle management & remote patient monitoring market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 53 Wearable AI market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 54 Patient engagement market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 55 Others market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 56 Medical AI market: End use outlook key takeaways (USD Billion)
  • Fig. 57 Medical AI market: End use movement analysis, 2025 & 2036
  • Fig. 58 Hospitals market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 59 Physician groups/clinics market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 60 Ambulatory / specialty care centers market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 61 Others market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 62 Pharmaceutical companies market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 63 Biotechnology companies market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 64 CROs / clinical research organizations market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 65 Patient market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 66 Payers market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 67 Others market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 68 Medical AI market: Patient journey outlook key takeaways (USD Billion)
  • Fig. 69 Medical AI market: Patient journey movement analysis, 2025 & 2036
  • Fig. 70 Prevention/wellness market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 71 Diagnostics market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 72 Treatment / intervention market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 73 Post-care / management market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 74 Medical AI market revenue, by region
  • Fig. 75 Global Medical AI market: Regional outlook and key takeaways
  • Fig. 76 Global Medical AI market: Regional movement analysis
  • Fig. 77 North America market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 78 U.S. key country dynamics
  • Fig. 79 U.S. market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 80 Canada key country dynamics
  • Fig. 81 Canada market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 84 Europe market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 85 UK key country dynamics
  • Fig. 86 UK market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 87 Germany key country dynamics
  • Fig. 88 Germany market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 89 France key country dynamics
  • Fig. 90 France market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 91 Italy key country dynamics
  • Fig. 92 Italy market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 93 Spain key country dynamics
  • Fig. 94 Spain market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 95 Denmark key country dynamics
  • Fig. 96 Denmark market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 97 Sweden key country dynamics
  • Fig. 98 Sweden market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 99 Norway key country dynamics
  • Fig. 100 Norway market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 101 Asia Pacific market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 102 Japan key country dynamics
  • Fig. 103 Japan market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 104 China key country dynamics
  • Fig. 105 China market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 106 India key country dynamics
  • Fig. 107 India market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 108 Thailand key country dynamics
  • Fig. 109 Thailand market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 110 South Korea key country dynamics
  • Fig. 111 South Korea market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 112 Australia key country dynamics
  • Fig. 113 Australia market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 114 Latin America market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 115 Brazil key country dynamics
  • Fig. 116 Brazil market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 117 Argentina key country dynamics
  • Fig. 118 Argentina market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 119 Middle East and Africa market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 120 South Africa key country dynamics
  • Fig. 121 South Africa market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 122 Saudi Arabia key country dynamics
  • Fig. 123 Saudi Arabia market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 124 UAE key country dynamics
  • Fig. 125 UAE market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 126 Kuwait key country dynamics
  • Fig. 127 Kuwait market estimates and forecasts, 2021 - 2036 (USD Million)
  • Fig. 128 Company categorization
  • Fig. 129 Company market position analysis, 2025
  • Fig. 130 Company market share analysis, 2025
  • Fig. 131 Strategy mapping